
At GenieUs, we recognize ALS as a pressing challenge with a high societal cost. With over 70% of ALS patients lacking a known molecular basis, our mission is to unveil the mysteries of this complex disease. We leverage cutting-edge genomics to provide robust in silico genetic understanding through our groundbreaking platform, the Deep integrated Genomic Analysis Platform - DiGAP™. This depth of patient genomic profiling will create valuable opportunities for the biopharma industry to develop precision diagnostic and therapeutic solutions for ALS patients. The DiGAP™ Deep Insight Report will…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.